Adverse drug events observed in patients with type 2 diabetes mellitus treated with 100 mg versus 300 mg canagliflozin: a systematic review and meta-analysis of published randomized controlled trials

Overview of attention for article published in BMC Pharmacology and Toxicology, April 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

So far, Altmetric has seen 13 X posts from 13 X users, with an upper bound of 37,280 followers.

RT @SEDiabetes: Efectos adversos Canaglifozina 300 vs 100 mg https://t.co/yEBCL9JoPV

RT @SEDiabetes: Efectos adversos Canaglifozina 300 vs 100 mg https://t.co/yEBCL9JoPV

RT @florencarral: Cana 300 no se asocia a mas efectos adversos que cana 100 https://t.co/UTYMp12KtR

RT @SEDiabetes: Efectos adversos Canaglifozina 300 vs 100 mg https://t.co/yEBCL9JoPV

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 9 additional X posts.